Pharmacological activity of DTPA linked to protein-based drug carrier systems.
Michaelis
Martin
M
Institut für Medizinische Virologie, Zentrum der Hygiene, Klinikum der J.W. Goethe-Universität, Paul Ehrlich Str. 40, 60596 Frankfurt am Main, Germany.
Langer
Klaus
K
Arnold
Sonja
S
Doerr
Hans-Wilhelm
HW
Kreuter
Jörg
J
Cinatl
Jindrich
J
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D004337:Drug Carriers / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D043942:Nanotubes / Q000737:chemistry; D009447:Neuroblastoma / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D010316:Particle Size; D004369:Pentetic Acid / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D012709:Serum Albumin / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D004337:Drug Carriers; D012709:Serum Albumin; D004369:Pentetic Acid